Detection and interpretation of altered methylation patterns in cancer cells
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Epigenetic alterations, such as abnormal DNA-methylation patterns, are associated with many human tumour types. New techniques have been developed to perform genome-wide screening for alterations in DNA-methylation patterns, not only to identify tumour-suppressor genes, but also to find patterns that can be used in diagnosis and prognosis. However, interpretation of differential methylation has proven difficult because the significance of methylation alterations depends on the genomic region, and functions of CpG islands at specific sites have not been fully clarified. What techniques can be used to identify new tumour suppressors and diagnostic markers?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROS influence the activity of epigenetic modulators, such as histone deacetylases (HDACs) or DNA methyltransferases (DNMTs) with consequences that are evident in the expression of the target genes38,39.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [39]
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
CpG Islands in vertebrate genomes
Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,353
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
Bell, A. C., & Felsenfeld, G. (2000) · Nature · doi:10.1038/35013100 · Cited by 1,746 · cited 1×
“), and defines regions for transcriptional regulatio”
Cited by
Items 401–482 of 482
Dai, F., He, M., Chen, B., & Hu, B. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.138891 · Cited by 2
Single Molecule Microarray Analysis
Hesse, J., Haselgrübler, T., Wechselberger, C., & Schütz, G. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374227-8.00010-9 · Cited by 2
Methylation-Specific Electrophoresis
Yokoyama, S., Matsuo, K., & Tanimoto, A. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3670-1_22 · Cited by 2
Epigenetics Meets CAR-T-Cell Therapy to Fight Cancer
Santourlidis, S., Araúzo-Bravo, M. J., Erichsen, L., & Bendhack, M. L. (2024) · Cancers · doi:10.3390/cancers16101941 · Cited by 2
Wu, T., Ji, X., Yun, Y., Wang, X., Gan, Y., Yu, F., & Zhang, Q. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333202 · Cited by 2
“DNA methylation refers to the epigenetic modification in which methyl groups are covalently added to DNA molecules [13].”
RetractedImproved PCR-BSP Assay for Multiplex Methylation Pattern Analysis in Minimal Amount of DNA
Wang, J., Yu, M., Li, K., Xiao, J., & Zhou, Y. (2009) · Molecular Biotechnology · doi:10.1007/s12033-009-9169-5 · Cited by 2
“However, the degradation of DNA during bisulfite treatment limits the capability of DNA methylation analysis [8], especially at the cell-specific level.”
BackgroundMethodDNA hypomethylation in plasma as a cancer biomarker: when less is more?
Henrique, R., & Jerónimo, C. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.905203 · Cited by 2
Kim, Y. H., Lee, W. K., Park, J. Y., & Kim, D. S. (2015) · Genes & Genomics · doi:10.1007/s13258-015-0277-2 · Cited by 2
“Third, different CGIs or regions within a CGI have different effects on gene expression (Ushijima 2005; Kim et al. 2010).”
BackgroundGoymer, P. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1759 · Cited by 2
Cai, L., Izumi, S., Abe, M., Imura, M., Yasugi, T., Wakazono, K., Ohnuki, Y., Kondo, A., & Ushijima, T. (2011) · PubMed · Cited by 2
Self-citationSong, M., Song, M., Choi, H., Ryu, W., Yoon, J.-S., Shin, C., Kim, Y.-J., & Ryu, J. (2011) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-011-0097-y · Cited by 2
Cheng, J., Yuan, M., Li, A.-L., Zhou, P., Shen, G., & Zhang, Y. (2014) · Genetics and Molecular Research · doi:10.4238/2014.september.12.9 · Cited by 2
Molecular Techniques for DNA Methylation Studies
Tost, J., & Gut, I. G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374537-8.00014-6 · Cited by 2
Development of Novel Pancreatic Tumor Biomarkers
Goggins, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_50 · Cited by 2
Fukuchi, H., Hayashida, Y., Inoue, K., & Sadamura, Y. (2019) · Genes to Cells · doi:10.1111/gtc.12717 · Cited by 2
“Epigenetic control in cancer cells has been reported in tumor suppressor genes (Ehrlich, 2009; Ushijima, 2005), suggest ing that FOXB2 may function like tumor suppressor gene.”
BackgroundNutrients, Histone Modifications, And Chromatin Remodeling In Chronic Inflammation
Delage, B., & Dashwood, R. H. (2009) · CRC Press eBooks · doi:10.1201/9781420063561.ch6 · Cited by 2
Bie, F., Wang, Z., Li, Y., Hong, Y., Han, T., Lv, F., Yang, S., Li, S., Li, X., Nie, P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.04.498641 · Cited by 1
Pu, Y., Wang, Z., Tao, S., Yang, E. J., Zhang, J., Han, Y., Wu, S., Ren, G., Chen, L.-J., Zhang, X., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01663-w · Cited by 1
Beyond mutations: epigenetic and fragmentomic landscapes of cfDNA in lung cancer
Liu, J., Schulz, L. S. E., & Zhou, Q. (2026) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2026.2665256 · Cited by 1
“Cancer cells exhibit widespread alterations in DNA methylation [42], and these epigenetic changes are considered early events in the development of cancer [43,44].”
Epigenetic Aberrant Hypermethylation of DNA in Endometrial Cancer: Application as a Biomarker
Ono, A., Kisu, I., Banno, K., Yanokura, M., Masuda, K., Kobayashi, Y., Tsuji, K., Ueki, A., Yamagami, W., Nomura, H., et al. (2011) · Journal of Cancer Therapy · doi:10.4236/jct.2011.25082 · Cited by 1
“DNA methylation in CpG islands in promoters upstream of the start of gene transcription has an important role in gene expression [4].”
BackgroundLehmann, U. (2010) · Der Pathologe · doi:10.1007/s00292-010-1300-7 · Cited by 4
Mutlu, M., Mutlu, P., Azarkan, S. Y., Bayır, Ö., Öcal, B., Saylam, G., & Korkmaz, M. (2020) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2020-0025 · Cited by 1
“Cancer cells generally show a drastic change in DNA methylation status, either exhibiting DNA hypomethylation, which causes overexpression of oncogenes or accompanying region-specific hypermethylation that results in silencing of tumor suppressor genes [16-18].”
BackgroundJing, A., & Han, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-19879-x · Cited by 1
“We measured the sensitivity of our method to the weight µ from a wide range of candidates [ 0, 0.2, 0.4, 0.6, 0.8, 1, 2, 4, 6, 8, 10 ] .”
MethodInfluentialCell Cycle, DNA Damage Repair Systems, and Impact of Redox Regulation in Cancer
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_8 · Cited by 2
Aberrant DNA Methylation in Cancer Cells
Ushijima, T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_6 · Cited by 1
Self-citationEpigenetic Epidemiology of Infectious Diseases
Ushijima, T., Furuichi, Y., Takeshima, H., & Hattori, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-94475-9_14 · Cited by 1
Self-citationGouws, C. (2011) · Boloka Institutional Repository (North-west University) · Cited by 1
The Role of Snf2-Related Proteins in Cancer
Owen‐Hughes, T. (2006) · Springer eBooks · doi:10.1007/3-540-37633-x_3 · Cited by 2
Duong, C. V. (2014) · Keele Research Repository (Keele University) · Cited by 1
Genomics Technologies as Tools in Drug Discovery
Semizarov, D., & Blomme, E. A. G. (2008) · Wiley eBooks · doi:10.1002/9780470409770.ch2 · Cited by 2
Perrin, D. (2008) · Dublin City University Open Access Institutional Repository (Dublin City University) · Cited by 1
Hendricks, W. P. D., Sekulić, A., Bryce, A. H., Murtaza, M., Ramos, P., & Trent, J. M. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm007 · Cited by 1
Herreros‐Pomares, A. (2020) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/137036 · Cited by 1
“Characteristics N % Age at surgery (median, range): 65 [26-85] Gender Male 202 82.”
Background4 Angiogenesis, Metastasis, and Epigenetics in Cancer
Plumb Claire, L., & Coomber, B. L. (2005) · Handbook of immunohistochemistry and in situ hybridization of human carcinomas · doi:10.1016/s1874-5784(05)80059-5
Payne, K. K. (2015) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/2ed4-9q46
“Aberrant CTA expression likely occurs due to epigenetic molecular alterations which arise during tumor progression; cancer cells display drastic changes in DNA methylation status, typically exhibiting global DNA hypomethylation as well as region-specific hypermethylation (122), resulting in irregular expression of CTA…”
BackgroundEnomoto, S., Maekita, T., Nakazawa, K., Yoshida, T., Watanabe, M., Mukoubayashi, C., Ohata, H., Iguchi, M., Yanaoka, K., Tamai, H., et al. (2013) · InTech eBooks · doi:10.5772/53116 · Cited by 1
“DNA methylation, along with mutations and chromosomal deletions, is a major factor in the gene inactivation in many cancers [27-29].”
BackgroundMethods for the Analysis of DNA Methylation
Rand, K. N., & Molloy, P. L. (2009) · Wiley eBooks · doi:10.1002/9783527626588.ch17
Introduction: Genomics and Personalized Medicine
Semizarov, D., & Blomme, E. A. G. (2008) · Wiley eBooks · doi:10.1002/9780470409770.ch1
Rodrigues, R. V. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2011.tde-10072012-140828
Effects of DNA methylation pattern on the chromatin structure
Useche, J., & Cristina, I. (2013)
Epigenomic Analysis in Toxicology
Ushijima, T., Okochi‐Takada, E., & Takeshima, H. (2009) · Wiley eBooks · doi:10.1002/9780470744307.gat230
Self-citationInvestigating the regulation of c-Fes non-receptor tyrosine kinase activation and gene expression
Shaffer, J. M. (2008) · D-Scholarship@Pitt (University of Pittsburgh)
Goymer, P. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1767
DNMT1 (DNA (cytosine-5-)-methyltransferase 1))
Arai, E., & Kanai, Y. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44376
Die Methylierung von Serum-DNA ist ein unabhängiger prognostischer Marker des kolorektalen Karzinoms
Wallner, M. (2008) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.8033
Designing of a novel GA based on fuzzy system for prediction of CpG islands in the human genome
Chuang, L., Chen, Y.-J., & Yang, C. (2009) · IEEE International Conference on Fuzzy Systems (FUZZ-IEEE) · doi:10.1109/fuzzy.2009.5277225
In Silico Cloning CsCCD8 in Cucumis sativus L. and Bioinformatics Analyzing Its Sequences
Xu, Q., Li, F., & Hu, B. (2011) · International Conference on Bioinformatics and Biomedical Engineering · doi:10.1109/icbbe.2011.5780027
Researchof the SPARC gene promoter and its clinical implication in pancreatic cancer
Gao, J., Song, J., Huang, H., Li, Z., Du, Y., Cao, J., Li, M., Lv, S., Han, L., & Gong, Y.-F. (2010)
Cancer classification by genome-wide and quantitative DNA methylationanalyses
Kaneda, A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777271.027
Early Biomarkers in Breast Cancer
Kaul-Ghanekar, R., Suryavanshi, S., & Raina, P. (2015) · CRC Press eBooks · doi:10.1201/b18015-6
Early Biomarkers in Breast Cancer
Raina, P. (2013) · CRC Press eBooks · doi:10.1201/b16389-28
H. pylori関連胃炎の自然史に基づく胃癌発生予防・早期発見
雅夫, 一. (2008) · 日本消化器がん検診学会雑誌 · doi:10.11404/jsgcs.46.355
Identification of differentially methylated regions (DMRs) of neuronatin in mice
Xu, Y., Liu, Z., Wang, T., Chen, X., Deng, J., Chen, M., & Li, Z. (2016) · SpringerPlus · doi:10.1186/s40064-016-3721-0
“DMRs with allele specific methylation have also been used in cancer diagnosis (Ushijima 2005; Bonin et al. 2016).”
MethodVon der Grundlagenforschung zur Routinediagnostik
Lehmann, U. (2010)
Aberrant DNA Methylation in Endometrial Cancer
Masuda, K., Banno, K., Yanokura, M., Tsuji, K., Kisu, I., Ueki, A., Kobayashi, Y., Nomura, H., Hirasawa, A., Susumu, N., et al. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-388415-2.00023-8
Future Perspective of DNA and Histone Methylation as Cancer Targets
Takeshima, H., & Ushijima, T. (2017) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-59786-7_21 · Cited by 1
Self-citationRole of the RFTS domain of Dnmt1 in maintenance DNA methylation
Garvilles, R. G. (2015) · Institutional Repositories DataBase (IRDB) · doi:10.18910/56075
Semizarov, D., & Blomme, E. A. G. (2008) · doi:10.1002/9780470409770.ch3
İnandıklıoğlu, N., Demırhan, O., Bayram, İ., & TANYEL, İ. A. (2020) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.676515
Cytogenetic Mechanisms in Endometrial Cancer
Khatuja, R., & Malakar, A. (2020) · Springer eBooks · doi:10.1007/978-981-15-5317-2_2
Montanari, M., Macaluso, M., & Giordano, A. (2013) · Springer eBooks · doi:10.1007/978-3-642-30574-0_29
Methylation regulation of MUC6 correlates with metastasis of gastric cancerPreprint
Shi, D., & Xi, X.-X. (2020) · doi:10.21203/rs.2.23506/v1
“carcinogenesis[24-26] and results in the inactivation of tumor suppressor genes[27,28].”
BackgroundHendricks, W. P. D., Sekulić, A., Bryce, A. H., Murtaza, M., Ramos, P., Lang, J. D., Whitsett, T. G., McDaniel, T. K., Rockne, R. C., Banovich, N. E., et al. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm007.pub2
Wu, G., Guo, Z., Chang, X., Kim, M. S., Nagpal, J. K., Liu, J., Mäki, J. M., Kivirikko, K. I., Ethier, S. P., Trink, B., et al. (2023) · doi:10.1158/0008-5472.c.6496391
Wu, G., Guo, Z., Chang, X., Kim, M. S., Nagpal, J. K., Liu, J., Mäki, J. M., Kivirikko, K. I., Ethier, S. P., Trink, B., et al. (2023) · doi:10.1158/0008-5472.c.6496391.v1
Gaudet, M. M., Campan, M., Figueroa, J. D., Yang, X. R., Lissowska, J., Pepłońska, B., Brinton, L. A., Rimm, D. L., Laird, P. W., García‐Closas, M., et al. (2023) · doi:10.1158/1055-9965.c.6514921.v1
Gaudet, M. M., Campan, M., Figueroa, J. D., Yang, X. R., Lissowska, J., Pepłońska, B., Brinton, L. A., Rimm, D. L., Laird, P. W., García‐Closas, M., et al. (2023) · doi:10.1158/1055-9965.c.6514921
Data from Three DNA Methylation Epigenotypes in Human Colorectal Cancer
Yagi, K., Akagi, K., Hayashi, H., Nagae, G., Tsuji, S., Isagawa, T., Midorikawa, Y., Nishimura, Y., Sakamoto, H., Seto, Y., et al. (2023) · doi:10.1158/1078-0432.c.6518326
Genetic and Epigenetic Dysregulation in Environmental Disease
Ramos, K. S., Hassanin, A. A. I., & Wang, Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00034-4
Santourlidis, S. (2025) · Genes · doi:10.3390/genes16091102 · Cited by 2
“Importantly, methylation extending into exonic regions does not necessarily block transcription initiation or elongation [10,11].”
Xu, H., Huang, K., Lin, Y., Gong, H., Ma, X., & Zhang, D. (2024) · Figshare · doi:10.6084/m9.figshare.26594321
Characterization of an auranofin-resistant ovarian cancer cell line A2780
Limaj, X. (2024) · theses.fr (ABES) · doi:10.70675/5f21b24bzd436z4168z8555zdc660e2b2aca · Cited by 1
Zhang, Y., Dong, J., Yang, J., Rao, Y., Deng, C., Bie, Y., & Liu, N. (2026) · ACS Sensors · doi:10.1021/acssensors.6c01085
Bai, Y., & Lu, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1955428
“Validation therefore requires disease-matched controls with gastritis, atrophy and metaplasia, not only healthy controls (3 – 8, 30 – 32, 71).”
Chávez, L. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10508
“This chemical treatment of DNA e ectively turns an epigenetic di erence into a genetic di erence unmethylated Cs are converted to Ts (by uracil) thereby enabling many new DNA methylation detection and analysis techniques [53, 83, 8, 100, 36, 106, 62, 60, 42, 9, 44].”
BackgroundSell, S., & Biava, P. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7696-2_31
Metadata
- Authors
- Ushijima, T.
- Affiliations
- National Cancer Center Research Institute (JP)
- Corresponding author
- Ushijima, Toshikazu
- ORCID
- Ushijima, Toshikazu
- Venue
- Nature Reviews Cancer
- Published
- 2005-02-18
- Volume
- 5
- Issue
- 3
- Pages
- 223-231
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1999464755
- Cited by
- 483
- References
- 90
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 9 · 2023: 13 · 2022: 13 · 2021: 4 · 2020: 17 · 2019: 17 · 2018: 9 · 2017: 12 · 2016: 15 · 2015: 25 · 2014: 26 · 2013: 36 · 2012: 30
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- DNA methylation, epigenetic modifications, cancer, tumor suppressor, diagnostic biomarkers, prognostic factors, CpG islands
- MeSH terms
- DNA, Neoplasm, Genetic Markers, Humans, Neoplasms, Promoter Regions, Genetic, Genes, Tumor Suppressor, Genome, CpG Islands, DNA Methylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.